Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's WhyZacks Investment Research • 04/29/26
BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) TherapyGlobeNewsWire • 04/15/26
Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 04/13/26
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 04/13/26
BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/13/26
BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental HealthGlobeNewsWire • 03/19/26
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational HighlightsGlobeNewsWire • 03/11/26
Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression TreatmentGlobeNewsWire • 03/04/26
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026GlobeNewsWire • 02/25/26
BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.GlobeNewsWire • 02/19/26
BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to CareGlobeNewsWire • 02/18/26
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™GlobeNewsWire • 01/21/26
BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)GlobeNewsWire • 01/12/26